InMed Pharmaceuticals Revenue Growth & History (INM)

InMed Pharmaceuticals reported $4.9M in revenue for fiscal 2025, an increase of 7.50% from the previous fiscal year.

View full InMed Pharmaceuticals company overview

InMed Pharmaceuticals annual revenue and growth

InMed Pharmaceuticals annual revenue

Fiscal yearPeriod endedRevenueChangeGrowth
20252025-06-30$4.9M$344,903+7.50%
20242024-06-30$4.6M$3.2M+236.64%
20232023-06-30$1.4M$00.00%
20222022-06-30$1.4M−$538,258−28.27%
20212021-06-30$1.9M——

InMed Pharmaceuticals revenue growth trends

InMed Pharmaceuticals's latest reported quarter, Q3 2026, generated $0 in revenue, a decrease of 100.00% year over year.

About the data

What revenue means

Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.

Financial data

Standardized company financials

TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.

Review InMed Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about INM yet. Start the conversation.

Write the first post